What does CUSIP 04269XAB1 represent in this 13F holders report?

CUSIP 04269XAB1 is the security identifier for 04269XAB1 - ARRAY BIOPHARMA INC - NOTE 2.625%12/0 used to aggregate holder disclosures.

How many institutions held 04269XAB1 - ARRAY BIOPHARMA INC - NOTE 2.625%12/0 in Q4 2017?

11 institutional investors reported 04269XAB1 - ARRAY BIOPHARMA INC - NOTE 2.625%12/0 for Q4 2017. Use the holders table for investor-level position and value details.

ARRAY BIOPHARMA INC - NOTE 2.625%12/0

CUSIP: 04269XAB1

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class: Debt / NOTE 2.625%12/0
Market price (% of par): 112.95%
Total 13F principal: $126,060,000
Principal change: +$126,060,000
Total reported market value: $142,050,000
Number of holders: 11
Value change: +$142,050,000
Number of buys: 11

Quarterly Holders Quick Answers

What is CUSIP 04269XAB1?
CUSIP 04269XAB1 identifies 04269XAB1 - ARRAY BIOPHARMA INC - NOTE 2.625%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2018

Recent filing periods for CUSIP 04269XAB1:

Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017

Institutional Holders of ARRAY BIOPHARMA INC - NOTE 2.625%12/0 as of Q4 2017

As of 31 Dec 2017, ARRAY BIOPHARMA INC - NOTE 2.625%12/0 was held by 11 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $126,060,000 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Allianz Asset Management GmbH, Redmile Group, LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Graham Capital Management, L.P., WOLVERINE ASSET MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, Linden Advisors LP, Verition Fund Management LLC, and CSS LLC/IL. This page lists 11 institutional bondholders reporting positions for the Q4 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price (% of par)	Principal	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.